on 03 Nov 2020
Last Applicant/ Owned by
CH-4123 Allschwil
CH
Serial Number
79274312 filed on 06th Nov 2019
Registration Number
6187268 registered on 03rd Nov 2020
Correspondent Address
Mary Margaret L. O'Donnell
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseases, hypertension, vasospasm associated with aneurysmal subarachnoid hemorrhage, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases, neurological disorders, diseases and disorder Read More
Pharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseases, hypertension, vasospasm associated with aneurysmal subarachnoid hemorrhage, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases, neurological disorders, diseases and disorders of the central nervous system, dementia, sleep disorders, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases, and cancer
No 79274312
No Service/Collective Mark
No SCFE0373WOUS
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
14th Mar 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
21st Feb 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
21st Feb 2021 | FINAL DISPOSITION PROCESSED |
03rd Feb 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
11th Dec 2020 | NEW REPRESENTATIVE AT IB RECEIVED |
03rd Nov 2020 | REGISTERED-PRINCIPAL REGISTER |
18th Aug 2020 | PUBLISHED FOR OPPOSITION |
18th Aug 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
29th Jul 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
14th Jul 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |